Sign In
Buy ILMN
$205.10
+0.0100 (+0.0049%)
At Close: Jul 31, 2026
Why Illumina (ILMN) is a Top Momentum Stock for the Long-Term
10:50am, Wednesday, 06'th May 2026
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Here's Why Illumina (ILMN) is a Strong Growth Stock
10:45am, Tuesday, 05'th May 2026
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
ILMN Stock Up on Q1 Earnings & Revenue Beat, Margins Expand, '26 View Up
10:11am, Friday, 01'st May 2026
Illumina stock jumps after Q1 earnings and revenue beat, with margin expansion and raised 2026 outlook signaling continued growth momentum.
Illumina, Inc. (ILMN) Q1 2026 Earnings Call Transcript
09:11pm, Thursday, 30'th Apr 2026
Illumina, Inc. (ILMN) Q1 2026 Earnings Call Transcript
Illumina (ILMN) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
09:00pm, Thursday, 30'th Apr 2026
The headline numbers for Illumina (ILMN) give insight into how the company performed in the quarter ended March 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimat
Illumina (ILMN) Tops Q1 Earnings and Revenue Estimates
07:26pm, Thursday, 30'th Apr 2026
Illumina (ILMN) came out with quarterly earnings of $1.15 per share, beating the Zacks Consensus Estimate of $1.05 per share. This compares to earnings of $0.97 per share a year ago.
Illumina Reports Financial Results for First Quarter of Fiscal Year 2026
04:05pm, Thursday, 30'th Apr 2026
SAN DIEGO, April 30, 2026 /PRNewswire/ -- Illumina, Inc. (Nasdaq: ILMN) ("Illumina" or the "company") today announced its financial results for the first quarter of fiscal year 2026. First quarter 202
Tempus AI vs. Illumina: Which Oncology Stock Is Worth Buying Now?
02:50pm, Thursday, 30'th Apr 2026
TEM and ILMN battle in precision oncology, but stronger stock gains, valuation and earnings outlook position ILMN as the more compelling pick now.
Unlocking Q1 Potential of Illumina (ILMN): Exploring Wall Street Estimates for Key Metrics
10:20am, Wednesday, 29'th Apr 2026
Looking beyond Wall Street's top-and-bottom-line estimate forecasts for Illumina (ILMN), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the qu
AnaptysBio, Inc. (ANAB) May Report Negative Earnings: Know the Trend Ahead of Q1 Release
11:02am, Monday, 27'th Apr 2026
AnaptysBio (ANAB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Caprock Group LLC Purchases 5,764 Shares of Illumina, Inc. $ILMN
03:59am, Saturday, 25'th Apr 2026
Caprock Group LLC grew its position in Illumina, Inc. (NASDAQ: ILMN) by 39.0% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission
Illumina (ILMN) Reports Next Week: Wall Street Expects Earnings Growth
11:04am, Thursday, 23'rd Apr 2026
Illumina (ILMN) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
09:56am, Thursday, 23'rd Apr 2026
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
Fortis Capital Advisors LLC Invests $1.26 Million in Illumina, Inc. $ILMN
04:16am, Monday, 20'th Apr 2026
Fortis Capital Advisors LLC bought a new position in Illumina, Inc. (NASDAQ: ILMN) in the undefined quarter, according to the company in its most recent disclosure with the SEC. The institutional inve
DRAGEN v4.5 supports Illumina's new TruPath Genome and 5-base assays, drives insights across germline, oncology, and multiomic workflows
09:15am, Thursday, 16'th Apr 2026
Illumina launches DRAGEN v4.5, unlocking deep biological signals in complex regions and challenging sample types for rare disease, oncology research New pangenome representation, default personalizati
